The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

作者: Paul C Donaghy , Ian G McKeith

DOI: 10.1186/ALZRT274

关键词: Dorsal motor nucleusDiseaseNeurosciencePhysical medicine and rehabilitationDementia with Lewy bodiesDementiaHyposmiaNeurologyParkinsonismPoison controlMedicine

摘要: Dementia with Lewy bodies (DLB) is the second most common type of degenerative dementia following Alzheimer’s disease (AD). DLB clinically and pathologically related to Parkinson's (PD) PD dementia, three disorders can be viewed as existing on a spectrum body disease. In recent years there has been concerted effort establish phenotypes AD in prodromal phase (before respective syndromes cognitive motor impairment are expressed). Evidence for presentation also emerging. This paper briefly reviews what known about clinical before discussing pathology how this relates potential biomarkers DLB. The presenting features broadly placed categories: (particularly nonamnestic impairments), behavioural/psychiatric phenomena (for example, hallucinations, rapid eye movement sleep behaviour disorder (RBD)) physical symptoms parkinsonism, decreased sense smell, autonomic dysfunction). Some noncognitive such constipation, RBD, hyposmia postural dizziness predate onset memory by several Pathological studies have found that earliest sites involvement olfactory bulb, dorsal nucleus vagal nerve, peripheral nervous system, including enteric brainstem. promising early markers include presence dysfunction or hyposmia, 123I-metaiodobenzylguanidine cardiac scintigraphy, measures substantia nigra skin biopsy α-synuclein nerves. absence disease-modifying therapies, diagnosis limited use clinic. That said, knowledge development could help clinicians identify cases where uncertain. Prodromal great importance research, identifying at an earlier stage may allow researchers investigate initial phases pathophysiology, develop treatments designed interrupt syndrome accurately patients likely benefit from these treatments.

参考文章(91)
Z. Ahmed, Y. T. Asi, A. Sailer, A. J. Lees, H. Houlden, T. Revesz, J. L. Holton, The neuropathology, pathophysiology and genetics of multiple system atrophy Neuropathology and Applied Neurobiology. ,vol. 38, pp. 4- 24 ,(2012) , 10.1111/J.1365-2990.2011.01234.X
Dawn Brooker, Jenny La Fontaine, Simon Evans, Jennifer Bray, Karim Saad, Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations International Journal of Geriatric Psychiatry. ,vol. 29, pp. 682- 693 ,(2014) , 10.1002/GPS.4066
Walter A. Kukull, Oscar Lopez, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Randall Woltjer, Christopher Clark, John Q. Trojanowski, Thomas J. Montine, James B. Leverenz, Ronald Hamilton, Debby W. Tsuang, Aimee Schantz, Darcy Vavrek, Eric B. Larson, RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy-Related Pathology in the Dementia Patient Brain Pathology. ,vol. 18, pp. 220- 224 ,(2008) , 10.1111/J.1750-3639.2007.00117.X
D. Weisman, M. Cho, C. Taylor, A. Adame, L. J. Thal, L. A. Hansen, In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution Neurology. ,vol. 69, pp. 356- 359 ,(2007) , 10.1212/01.WNL.0000266626.64913.0F
Daniela Berg, Stefanie Behnke, Klaus Seppi, Jana Godau, Stefanie Lerche, Philipp Mahlknecht, Inga Liepelt-Scarfone, Christoph Pausch, Niko Schneider, Alexandra Gaenslen, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Heike Stockner, Stefan Kiechl, Johann Willeit, Arno Gasperi, Klaus Fassbender, Thomas Gasser, Werner Poewe, Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease. Movement Disorders. ,vol. 28, pp. 216- 219 ,(2013) , 10.1002/MDS.25192
Hirotake Uchikado, Wen-Lang Lin, Michael W. DeLucia, Dennis W. Dickson, Alzheimer disease with amygdala lewy bodies : A distinct form of α-synucleinopathy Journal of Neuropathology and Experimental Neurology. ,vol. 65, pp. 685- 697 ,(2006) , 10.1097/01.JNEN.0000225908.90052.07
Thomas G. Beach, , Charles H. Adler, LihFen Lue, Lucia I. Sue, Jyothi Bachalakuri, Jonette Henry-Watson, Jeanne Sasse, Sarah Boyer, Scophil Shirohi, Reed Brooks, Jennifer Eschbacher, Charles L. White, Haru Akiyama, John Caviness, Holly A. Shill, Donald J. Connor, Marwan N. Sabbagh, Douglas G. Walker, Unified Staging System for Lewy Body Disorders: Correlation with Nigrostriatal Degeneration, Cognitive Impairment and Motor Dysfunction Acta Neuropathologica. ,vol. 117, pp. 613- 634 ,(2009) , 10.1007/S00401-009-0538-8
Glenda M. Halliday, Yun Ju C. Song, Antony J. Harding, Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease Journal of Neural Transmission. ,vol. 118, pp. 713- 719 ,(2011) , 10.1007/S00702-011-0641-6
Lihai Yu, Jinquan Cui, Prashanth K. Padakanti, Laura Engel, Devika P. Bagchi, Paul T. Kotzbauer, Zhude Tu, Synthesis and in vitro evaluation of α-synuclein ligands. Bioorganic & Medicinal Chemistry. ,vol. 20, pp. 4625- 4634 ,(2012) , 10.1016/J.BMC.2012.06.023